Skip to content

13F-HR filed by MPM ASSET MANAGEMENT LLC

MPM ASSET MANAGEMENT LLC filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 9 holding rows worth $262,550,000.

Accession
0000950123-22-011903
Filed
2022-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2022

A holdings report, 9 entries on the cover page, a total value of $262,550,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $262,550,000 with VALUE read as thousands by filing date, 13F file number 028-13379. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ENTRADA THERAPEUTICS INC COM29384C108Stock4,425,784$69,750,000thousands by filing date
DYNE THERAPEUTICS INC COM26818M108Stock4,951,303$62,882,000thousands by filing date
ITEOS THERAPEUTICS INC46565G104COM2,738,785$52,174,000thousands by filing date
REPARE THERAPEUTICS INC760273102COM2,242,636$27,203,000thousands by filing date
WEREWOLF THERAPEUTICS INC95075A107CMN4,284,172$19,322,000thousands by filing date
AMRYT PHARMA LTD - SPNR ADR03217L106COMMON EQUITY2,668,843$18,468,000thousands by filing date
TCR2 THERAPEUTICS INC87808K106COM4,050,865$7,292,000thousands by filing date
HARPOON THERAPEUTICS INC41358P106COM3,131,388$3,037,000thousands by filing date
ONCORUS INC68236R103COM2,849,464$2,422,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-22-011903this filing2022-11-14acceptance time not in the bulk data set